Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest EndoChoice Inc. Stories

2014-03-26 08:28:33

FuseColonoscopy.org serves as key portal to dispel fears and concerns about colonoscopy ATLANTA, March 26, 2014 /PRNewswire/ -- EndoChoice Inc.(® )maker of the Fuse(TM) Full Spectrum Endoscopy(TM) system that allows doctors to see more of the GI tract than ever before today announced the launch of FuseColonoscopy.org to provide patients with the latest information on colorectal cancer screening. The release is planned to coincide with National Colorectal Cancer Awareness Month that...

2014-03-19 08:25:09

- Fuse(TM) Colonoscopy Dramatically Outperforms Standard Forward-Viewing Colonoscopes - ATLANTA, March 19, 2014 /PRNewswire/ -- EndoChoice® today announced that positive results of a pivotal comparison study of standard forward-viewing colonoscopy (SFV) and EndoChoice's Full Spectrum Endoscopy(TM) System (Fuse(TM)) were published in the March issue of The Lancet Oncology. To view the multimedia version of this release, please follow this link:...

2014-01-09 08:29:28

Company seeks to further the understanding and treatment of GI disease ATLANTA, Jan. 9, 2014 EndoChoice(®) today announced the launch of its Investigator-Initiated Study Program (IIS) to further build clinical evidence for the Fuse(TM) Endoscopy System. The Fuse IIS Program will provide research grants to interested researchers to support independent, investigator-initiated research that is scientifically compelling and consistent with advancing the understanding of the clinical...

2014-01-08 12:30:27

International Courses Draw More than 1,500 Doctors NEW YORK, Jan. 8, 2014 /PRNewswire/ -- The Fuse(TM), Full Spectrum Endoscopy(TM) system from EndoChoice® was featured in continuing medical education courses last month for audiences of gastroenterologists from around the world. At the Amsterdam Live Endoscopy course in Amsterdam, The Netherlands and the 37th Annual New York Course, sponsored by the New York Society for Gastrointestinal Endoscopy (NYSGE) in New York, NY, procedures...

2013-10-29 08:34:14

Company Continues Rapid Growth and Eyes Further Expansion in 2014 ATLANTA, Oct. 29, 2013 /PRNewswire/ -- The fastest growing medical technology company in the United States announced the receipt of multiple awards today. Following the launch of the Fuse(TM) system, EndoChoice® has received multiple awards within the last month linked to the rapid growth of the company's revenue and global expansion. EndoChoice received the Hire Power Award by Inc. Magazine, was selected as one of...

2013-10-28 12:25:40

Full Spectrum Endoscopy Welcomed by Doctors at Medical Conferences ATLANTA, Oct. 28, 2013 /PRNewswire/ -- Now doctors performing flexible endoscopy have a new tool available to help them see more anatomy and facilitate diagnoses in the upper GI tract. Traditional gastroscopes that have been available to endoscopists provide a field of view limited to about 140 degrees. EndoChoice(®) today announced the FDA had provided 510(k) clearance of its new Fuse(TM) Gastroscope that has a...

2013-05-18 12:20:12

EndoChoice's Fuse system receives FDA 510(k) Clearance ORLANDO, Fla., May 18, 2013 /PRNewswire/ -- Although colonoscopy exams prevent many colon cancer deaths(1) and are considered the most sensitive method for detecting colorectal cancers(2), the procedure is not completely effective in preventing cancer cases(3). EndoChoice(®) Inc. today unveiled research that shows that its new Fuse(TM) system significantly improves the accuracy of this procedure and greatly reduces the...

2010-04-29 13:07:00

ALPHARETTA, Ga., April 29 /PRNewswire/ -- EndoChoice, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its BONASTENT® Fully Covered Esophageal Stent for the treatment of malignant esophageal obstructions, and its BONASTENT Uncovered Biliary Stent for the treatment of malignant biliary obstructions. With over 8,000 placements worldwide, the BONASTENT platform has provided physicians treating malignant...

2010-04-07 10:25:00

ALPHARETTA, Ga., April 7 /PRNewswire/ -- EndoChoice, Inc. announced today that it has acquired Pathworks Anatomic Pathology Laboratory. Founded in 1989, Pathworks is a College of American Pathologists (CAP) accredited national reference laboratory located in Atlanta, GA. Robert Smith, MD, founder of the laboratory, will assume the Medical Director position of EndoChoice Pathology, a wholly-owned subsidiary of EndoChoice, Inc. "We are excited to leverage our GI expertise and join the...

2010-03-18 05:00:00

ALPHARETTA, Ga., March 18 /PRNewswire/ -- EndoChoice, Inc. strengthens its position as the leader in endoscopy industry with the launch of a new CEU program and a complete line of products focused on efficient and effective endoscope reprocessing. "Incidents of pathogen transmission related to flexible endoscopy continue to be reported in the media, and ECRI Institute continues to receive reports of potential endoscopy-related cross-contamination in facilities around the United States,"...